Mindfulness-Based Sleep Program for Depression During Pregnancy
(STRIDE P Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist pregnant women experiencing insomnia (trouble sleeping) in preventing depression before and after birth. It tests a mindfulness-based sleep program called PUMAS (Perinatal Understanding of Mindful Awareness for Sleep), which combines sleep strategies and mindfulness exercises through online sessions. Participants will either try PUMAS or receive usual treatment options like sleep aids and therapy. Pregnant women between weeks 14 and 31, who have experienced trouble sleeping for over a month and have no major depression, might be suitable candidates. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of participants.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that you should not be currently engaged in therapy for major depression or insomnia disorder.
What prior data suggests that the mindfulness-based sleep program is safe for pregnant women?
Research shows that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) is generally well-tolerated by pregnant women with insomnia. In earlier studies, participants experienced better sleep and less depression and mental stress. No serious side effects were reported from PUMAS. This therapy uses mindfulness techniques, combining sleep strategies with meditation exercises specifically designed for pregnancy. Although researchers continue to study this treatment, it seems safe and shows promise in improving sleep and mental well-being.12345
Why are researchers excited about this trial?
Researchers are excited about the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) because it offers a new approach to managing prenatal insomnia, which is often treated with sleep aids, melatonin, or cognitive-behavioral therapy. PUMAS is unique because it combines behavioral sleep strategies with mindfulness exercises specifically tailored for pregnancy. Another exciting feature is its delivery method; PUMAS is conducted through telemedicine, making it accessible for expectant mothers who may have difficulty attending in-person sessions. This combination of tailored mindfulness and convenient access could significantly improve sleep quality for pregnant individuals experiencing depression.
What evidence suggests that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) program might be an effective treatment for perinatal depression?
Research has shown that the Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) program, which participants in this trial may receive, can significantly help pregnant women by reducing insomnia, depression, and mental restlessness. Women in studies who engaged with PUMAS experienced substantial improvements in sleep quality. The program combines simple sleep techniques with mindfulness exercises to reduce mental stress that can exacerbate sleep problems. Available through telemedicine, it offers expecting mothers easy and convenient access. Overall, PUMAS shows promise for improving sleep and may help lower the risk of depression during pregnancy.12356
Who Is on the Research Team?
David A Kalmbach, PhD
Principal Investigator
Henry Ford Health
Are You a Good Fit for This Trial?
This trial is for pregnant women between weeks 14-31 who are not currently in therapy for major depression or insomnia, have no current severe depression or long-term insomnia disorder, and score moderately on the Insomnia Severity Index. They should not be at high risk of pregnancy complications nor work night shifts or plan extensive travel soon.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the PUMAS intervention or treatment-as-usual for prenatal insomnia, including six weekly 60-minute sessions delivered via telemedicine
Follow-up
Participants are monitored for changes in insomnia symptoms, cognitive arousal, and perinatal depression monthly for 1 year after childbirth
What Are the Treatments Tested in This Trial?
Interventions
- Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor